Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quotient Limited QTNTQ

Healthcare Medical Devices

Recent & Breaking News (OTCPK:QTNTQ)

Quotient Limited Provides Positive Updates on MosaiQ's Initial Serological Disease Screening and Expanded Immunohematology Microarrays, on Hypercare Launch and on a Successful Facility Audit and Reports Second Quarter Fiscal 2020 Financial Results

GlobeNewswire November 4, 2019

Quotient Announces Positive Preliminary Results from the Initial Serological Disease Screening US Field Trial

GlobeNewswire October 31, 2019

Quotient Limited to Report Second Quarter 2020 Financial Results and Host Conference Call

GlobeNewswire October 21, 2019

Quotient Announces Positive Verification and Validation Results for Extended Immunohematology Microarray and Updates on Hypercare Sites and Revenue Performance in the Quarter

GlobeNewswire October 17, 2019

Quotient Limited Provides Updates on European Hypercare Launch, the CE Mark Submission and U.S. Field Trial for the Initial Serological Disease Screening Microarray, and Reports First Quarter Fiscal 2020 Results

GlobeNewswire August 5, 2019

Quotient Limited to Report First Quarter 2020 Financial Results and Host Conference Call

GlobeNewswire July 22, 2019

Quotient Board Announces Contract Extension of CEO Franz Walt

GlobeNewswire July 2, 2019

Quotient Limited Announces the Submission of the Initial SDS Microarray CE mark Filing for MosaiQ(TM)

GlobeNewswire July 1, 2019

Quotient Limited to Participate in the Raymond James Life Sciences and MedTech Conference

GlobeNewswire June 5, 2019

Quotient Limited Recaps Recent Milestone Achievement and Updates on the Initial Serological Disease Screening CE Mark Submission, planned 2019 US Field Trials and Reports Record Financial Results

GlobeNewswire May 28, 2019

Quotient Limited to Participate in the Jefferies 2019 Healthcare Conference

GlobeNewswire May 21, 2019

Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call

GlobeNewswire May 14, 2019

Quotient Limited Receives European CE Mark for its Initial IH Microarray

GlobeNewswire May 1, 2019

Quotient Limited Announces Initial SDS EU Field Trial Performance Data for MosaiQ(TM)

GlobeNewswire April 24, 2019

Quotient Limited to Participate in the Cowen and Company 39th Annual Health Care Conference

GlobeNewswire March 7, 2019

Quotient Limited to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 15, 2019

Quotient Limited Provides an Update on Extended Immunohematology Microarray Performance and on the Commencement of the Initial Serological Disease Screening Field Trial together with Third Quarter Fiscal 2019 Results

GlobeNewswire January 31, 2019

Quotient Limited to Report Fiscal Third Quarter 2019 Financial Results and Host Conference Call

GlobeNewswire January 17, 2019

Quotient Limited Announces Receipt of the ISO 13485:2016 Certification of its State of the Art MosaiQ™ Microarray Manufacturing Facility

GlobeNewswire December 11, 2018

Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares

GlobeNewswire December 11, 2018